Alternative intronic polyadenylation (IPA) can generate truncated protein isoforms with significantly altered functions. Here, we describe 31 dominant-negative, secreted variant isoforms of receptor tyrosine kinases (RTKs) that are produced by activation of intronic poly(A) sites. We show that blocking U1-snRNP can activate IPA, indicating a larger role for U1-snRNP in RNA surveillance. Moreover, we report the development of an antisense-based method to effectively and specifically activate expression of individual soluble decoy RTKs (sdRTKs) to alter signaling, with potential therapeutic implications. In particular, a quantitative switch from signal transducing full-length vascular endothelial growth factor receptor-2 (VEGFR2/KDR) to a dominant-negative sKDR results in a strong antiangiogenic effect both on directly targeted cells and on naive cells exposed to conditioned media, suggesting a role for this approach in interfering with angiogenic paracrine and autocrine loops.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781938PMC
http://dx.doi.org/10.1016/j.molcel.2011.08.009DOI Listing

Publication Analysis

Top Keywords

soluble decoy
8
receptor tyrosine
8
tyrosine kinases
8
intronic polya
8
induction antagonistic
4
antagonistic soluble
4
decoy receptor
4
kinases intronic
4
polya activation
4
activation alternative
4

Similar Publications

The increasing utilization of deep learning models in drug repositioning has proven to be highly efficient and effective. In this study, we employed an integrated deep-learning model followed by traditional drug screening approach to screen a library of FDA-approved drugs, aiming to identify novel inhibitors targeting the TNF-α converting enzyme (TACE). TACE, also known as ADAM17, plays a crucial role in the inflammatory response by converting pro-TNF-α to its active soluble form and cleaving other inflammatory mediators, making it a promising target for therapeutic intervention in diseases such as rheumatoid arthritis.

View Article and Find Full Text PDF

Plasma Protein Biomarkers of Spirometry Measures of Impaired Lung Function.

Chest

November 2024

Framingham Heart Study, Framingham, MA; Population Sciences Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD. Electronic address:

Background: Impaired pulmonary function carries significant risks for lung, cardiovascular, and metabolic disorders.

Research Question: Can circulating protein biomarkers of pulmonary function provide insight into the pathophysiologic features of lung function impairment and links to comorbidities?.

Study Design And Methods: We analyzed plasma levels of 2,922 proteins in 32,493 UK Biobank participants (53% female; mean [SD] age, 57 [8] years) to investigate their associations with spirometry measures of lung function (FEV, FVC, FEV to FVC ratio), and with obstructive (n = 4,713) and restrictive (n = 3,886) spirometry patterns.

View Article and Find Full Text PDF

Background: The receptor for advanced glycation end product (RAGE) is a transmembrane receptor accelerating a pro-inflammatory signal. RAGE signalling is promoted by decreased soluble isoform of RAGE (sRAGE), which is a decoy receptor for RAGE ligands, and RAGE SNP rs2070600 minor allele. In Caucasian and Japanese cohorts, low circulatory sRAGE levels and presence of the minor allele are associated with poor survival of idiopathic pulmonary fibrosis (IPF) and increased disease susceptibility to interstitial lung disease, respectively.

View Article and Find Full Text PDF
Article Synopsis
  • Soluble CD163 (sCD163) is a key inflammatory mediator linked to both acute and chronic inflammation, and its levels in the body reflect the presence of CD163-expressing macrophages.
  • The shedding of the CD163 receptor leads to increased sCD163 concentrations, which plays various roles including scavenging hemoglobin, serving as a macrophage marker, and affecting immune responses.
  • Elevated sCD163 levels are associated with the severity and progression of various diseases like asthma, sepsis, diabetes, and rheumatoid arthritis, highlighting its importance in disease diagnosis and management.
View Article and Find Full Text PDF

In Silico Design of miniACE2 Decoys with In Vitro Enhanced Neutralization Activity against SARS-CoV-2, Encompassing .

Int J Mol Sci

October 2024

Unidad de Ingeniería Celular y Molecular, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, IDCBIS, Bogotá 111611, Colombia.

The COVID-19 pandemic has overwhelmed healthcare systems and triggered global economic downturns. While vaccines have reduced the lethality rate of SARS-CoV-2 to 0.9% as of October 2024, the continuous evolution of variants remains a significant public health challenge.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!